The next generation of enrollment analytics is moving far beyond traditional demographic and clinica...
Immunotherapy trials present unique enrollment challenges that can have life-threatening consequence...
One of the most persistent problems I encounter in clinical operations is the artificial separation ...
The recent FDA approval of inavolisib for PIK3CA-mutated breast cancer offers valuable insights into...
The traditional approach to enrollment monitoring (discovering problems during quarterly reviews) is...
Machine learning is fundamentally transforming how we approach patient selection in clinical trials....
In my experience, trials with thoughtful biomarker-driven stratification consistently outperform tho...
Regulatory agencies don't just review your efficacy data. They thoroughly examine your patient popul...
In 2025, it's shocking how many clinical trials still rely on PDF-based enrollment documentation. Th...
When most clinical teams think about enrollment data, they focus on the basics: age, gender, and med...
After years of working across oncology, immunology, cardiovascular, infectious disease, and neurolog...